MedTrace Logo

A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers

NCT03577626 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-07-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of food on the PK of a single dose of 52.5 mg Hemay005 in healthy subjects.

Conditions

Interventions

DRUG

Hemay005

Hemay005 tablets will be taken orally in dose of 52.5mg at fasted dosing on period one followed by fed dosing on period two.

DRUG

Hemay005

Hemay005 tablets will be taken orally in dose of 52.5mg at fed dosing on period one followed by fasted dosing on period two

Sponsors & Collaborators

  • Tianjin Hemay Bio-Tech Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Hongyun Wang, Doctor · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2018-11-10
Completion
2019-03-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577626 on ClinicalTrials.gov